Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

(18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy.

van Gómez López O, García Vicente AM, Honguero Martínez AF, Jiménez Londoño GA, Vega Caicedo CH, León Atance P, Soriano Castrejón ÁM.

Transl Lung Cancer Res. 2015 Jun;4(3):228-35. doi: 10.3978/j.issn.2218-6751.2015.05.07.

2.

Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial.

Evangelista L, Cuocolo A, Pace L, Mansi L, Del Vecchio S, Miletto P, Sanfilippo S, Pellegrino S, Guerra L, Pepe G, Peluso G, Salvatore M, Galicchio R, Zuffante M, Annunziata S, Farsad M, Chiaravalloti A, Spadafora M.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1898-1907. doi: 10.1007/s00259-018-4016-1. Epub 2018 May 7.

PMID:
29736699
3.

PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology.

Sim YT, Goh YG, Dempsey MF, Han S, Poon FW.

Lung. 2013 Dec;191(6):625-32. doi: 10.1007/s00408-013-9500-6. Epub 2013 Sep 8.

PMID:
24013495
4.

18F-FDG PET/CT diagnostic performance in solitary and multiple pulmonary nodules detected in patients with previous cancer history: reports of 182 nodules.

Taralli S, Scolozzi V, Foti M, Ricciardi S, Forcione AR, Cardillo G, Calcagni ML.

Eur J Nucl Med Mol Imaging. 2018 Dec 8. doi: 10.1007/s00259-018-4226-6. [Epub ahead of print]

PMID:
30535767
5.

[Development of a predicting model to estimate the probability of malignancy of solitary pulmonary nodules].

Tian R, Su MG, Tian Y, Li FL, Kuang AR.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 May;43(3):404-8. Chinese.

PMID:
22812247
6.

Dynamic contrast-enhanced MRI versus 18F-FDG PET/CT: Which is better in differentiation between malignant and benign solitary pulmonary nodules?

Feng F, Qiang F, Shen A, Shi D, Fu A, Li H, Zhang M, Xia G, Cao P.

Chin J Cancer Res. 2018 Feb;30(1):21-30. doi: 10.21147/j.issn.1000-9604.2018.01.03.

7.

Diagnostic Performance of (18)F-Fluorodeoxyglucose in 162 Small Pulmonary Nodules Incidentally Detected in Subjects Without a History of Malignancy.

Calcagni ML, Taralli S, Cardillo G, Graziano P, Ialongo P, Mattoli MV, Di Franco D, Caldarella C, Carleo F, Indovina L, Giordano A.

Ann Thorac Surg. 2016 Apr;101(4):1303-9. doi: 10.1016/j.athoracsur.2015.10.072. Epub 2016 Jan 26.

PMID:
26822348
8.

Accuracy of PET/CT in characterization of solitary pulmonary lesions.

Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, Czernin J, Schiepers C.

J Nucl Med. 2007 Feb;48(2):214-20.

9.

Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules.

Dabrowska M, Krenke R, Korczynski P, Maskey-Warzechowska M, Zukowska M, Kunikowska J, Orłowski T, Chazan R.

Medicine (Baltimore). 2015 Apr;94(15):e666. doi: 10.1097/MD.0000000000000666.

10.

Sensitivity of (18)F-FDG PET in evaluation of solitary pulmonary nodules.

Yilmaz F, Tastekin G.

Int J Clin Exp Med. 2015 Jan 15;8(1):45-51. eCollection 2015. Review.

11.

What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions?

Kunikowska J, Matyskiel R, Toutounchi S, Grabowska-Derlatka L, Koperski L, Królicki L.

Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2273-80. doi: 10.1007/s00259-014-2844-1. Epub 2014 Jul 16.

12.

[Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].

Martins Rde C, Almeida SA, Siciliano AA, Landesmann MC, Silva FB, Franco CA, Fonseca LM.

J Bras Pneumol. 2008 Jul;34(7):473-80. Portuguese.

13.

The diagnostic role of dual-phase (18)F-FDG PET/CT in the characterization of solitary pulmonary nodules.

Demir Y, Polack BD, Karaman C, Ozdoğan O, Sürücü E, Ayhan S, Akkoçlu A, Ozdemir N.

Nucl Med Commun. 2014 Mar;35(3):260-7. doi: 10.1097/MNM.0000000000000049.

PMID:
24468852
14.

The diagnostic accuracy of integrated positron emission tomography/computed tomography in the evaluation of pulmonary mass lesions in a tuberculosis-endemic area.

du Toit R, Shaw JA, Irusen EM, von Groote-Bidlingmaier F, Warwick JM, Koegelenberg CF.

S Afr Med J. 2015 Nov 5;105(12):1049-52. doi: 10.7196/SAMJ.2015.v105i12.10300.

PMID:
26792164
15.

Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area.

Sathekge MM, Maes A, Pottel H, Stoltz A, van de Wiele C.

S Afr Med J. 2010 Sep 7;100(9):598-601.

PMID:
20822650
16.

Novel and convenient method to evaluate the character of solitary pulmonary nodule-comparison of three mathematical prediction models and further stratification of risk factors.

Xiao F, Liu D, Guo Y, Shi B, Song Z, Tian Y, Liang C.

PLoS One. 2013 Oct 29;8(10):e78271. doi: 10.1371/journal.pone.0078271. eCollection 2013.

17.

Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial.

Spadafora M, Pace L, Evangelista L, Mansi L, Del Prete F, Saladini G, Miletto P, Fanti S, Del Vecchio S, Guerra L, Pepe G, Peluso G, Nicolai E, Storto G, Ferdeghini M, Giordano A, Farsad M, Schillaci O, Gridelli C, Cuocolo A.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1908-1914. doi: 10.1007/s00259-018-4043-y. Epub 2018 May 5.

PMID:
29730697
18.

Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.

Kim BH, Kim SJ, Kim H, Jeon YK, Kim SS, Kim IJ, Kim YK.

Nucl Med Commun. 2013 Sep;34(9):868-76. doi: 10.1097/MNM.0b013e328362d2d7.

PMID:
23797273
19.

Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.

Orlacchio A, Schillaci O, Antonelli L, D'Urso S, Sergiacomi G, Nicolì P, Simonetti G.

Radiol Med. 2007 Mar;112(2):157-73. Epub 2007 Mar 19. English, Italian.

PMID:
17361379
20.

[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].

Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):364-8. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.010. Chinese.

PMID:
22883458

Supplemental Content

Support Center